{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:27:58Z","timestamp":1790695678199,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/laban0209-55","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T14:43:50Z","timestamp":1232635430000},"page":"55-60","source":"Crossref","is-referenced-by-count":36,"title":["Insights into modeling streptozotocin-induced diabetes in ICR mice"],"prefix":"10.1038","volume":"38","author":[{"given":"Yaron","family":"Dekel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat","family":"Glucksam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Elron-Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimona","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFlaban020955_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/bip.20734","volume":"88","author":"JP Mayer","year":"2007","unstructured":"Mayer, J.P., Zhang, F. & DiMarchi, R.D. Insulin structure and function. Biopolymers 88, 687\u2013713 (2007).","journal-title":"Biopolymers"},{"key":"BFlaban020955_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1262-3636(06)72804-X","volume":"32","author":"V Lassmann-Vague","year":"2006","unstructured":"Lassmann-Vague, V. & Raccah, D. Alternatives routes of insulin delivery. Diabetes Metab. 32, 513\u2013522 (2006).","journal-title":"Diabetes Metab."},{"key":"BFlaban020955_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2337\/diacare.27.1.239","volume":"27","author":"WT Cefalu","year":"2004","unstructured":"Cefalu, W.T. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care 27, 239\u2013246 (2004).","journal-title":"Diabetes Care"},{"key":"BFlaban020955_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","volume":"50","author":"T Szkudelski","year":"2001","unstructured":"Szkudelski, T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537\u2013546 (2001).","journal-title":"Physiol. Res."},{"key":"BFlaban020955_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen, S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51, 216\u2013226 (2008).","journal-title":"Diabetologia"},{"key":"BFlaban020955_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1248\/bpb.22.988","volume":"22","author":"M Ito","year":"1999","unstructured":"Ito, M., Kondo, Y., Nakatani, A. & Naruse, A. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. Biol. Pharm. Bull. 22, 988\u2013989 (1999).","journal-title":"Biol. Pharm. Bull."},{"key":"BFlaban020955_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1382-6689(00)00064-8","volume":"9","author":"M Ito","year":"2001","unstructured":"Ito, M., Kondo, Y., Nakatani, A., Hayashi, K. & Naruse, A. Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ. Toxicol. Pharmacol. 9, 71\u201378 (2001).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"BFlaban020955_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1248\/bpb.29.1110","volume":"29","author":"K Hayashi","year":"2006","unstructured":"Hayashi, K., Kojima, R. & Ito, M. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol. Pharm. Bull. 29, 1110\u20131119 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"BFlaban020955_CR9","doi-asserted-by":"publisher","first-page":"42345","DOI":"10.1074\/jbc.M507110200","volume":"280","author":"K Huang","year":"2005","unstructured":"Huang, K., Dong, J., Phillips, N.B., Carey, P.R. & Weiss, M.A. Proinsulin is refractory to protein fibrillation: topological protection of a precursor protein from cross-beta assembly. J. Biol. Chem. 280, 42345\u201342355 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFlaban020955_CR10","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.lfs.2006.07.027","volume":"79","author":"MJ Kim","year":"2006","unstructured":"Kim, M.J. & Kim, H.K. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice. Life Sci. 79, 2288\u20132292 (2006).","journal-title":"Life Sci."},{"key":"BFlaban020955_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2005.09.051","volume":"524","author":"C Nozaki","year":"2005","unstructured":"Nozaki, C., Saitoh, A., Tamura, N. & Kamei, J. Antinociceptive effect of oxycodone in diabetic mice. Eur. J. Pharmacol. 524, 75\u201379 (2005).","journal-title":"Eur. J. Pharmacol."},{"key":"BFlaban020955_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1532-5415.1998.tb06005.x","volume":"46","author":"IG Lerman","year":"1998","unstructured":"Lerman, I.G. et al. The prevalence of diabetes and associated coronary risk factors in urban and rural older Mexican populations. J. Am. Geriatr. Soc. 46, 1387\u20131395 (1998).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFlaban020955_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1017\/S0007114507450310","volume":"97","author":"WC Chiu","year":"2007","unstructured":"Chiu, W.C., Hou, Y.C., Yeh, C.L., Hu, Y.M. & Yeh, S.L. Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis. Br. J. Nutr. 97, 685\u2013691 (2007).","journal-title":"Br. J. Nutr."},{"key":"BFlaban020955_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.lfs.2004.12.036","volume":"77","author":"C Jong-Yuh","year":"2005","unstructured":"Jong-Yuh, C. & Mei-Fen, S. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci. 77, 980\u2013990 (2005).","journal-title":"Life Sci."},{"key":"BFlaban020955_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11095-005-9444-5","volume":"23","author":"J Cheng","year":"2006","unstructured":"Cheng, J. et al. Magnetically responsive polymeric micro-particles for oral delivery of protein drugs. Pharm. Res. 23, 557\u2013564 (2006).","journal-title":"Pharm. Res."},{"key":"BFlaban020955_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","volume":"117","author":"C Damge","year":"2007","unstructured":"Damge, C., Maincent, P. & Ubrich, N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control. Release 117, 163\u2013170 (2007).","journal-title":"J. Control. Release"},{"key":"BFlaban020955_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0039-6060(98)70185-0","volume":"123","author":"WE Fisher","year":"1998","unstructured":"Fisher, W.E., Muscarella, P., Boros, L.G. & Schirmer, W.J. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse. Surgery 123, 315\u2013320 (1998).","journal-title":"Surgery"},{"key":"BFlaban020955_CR18","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/S0024-3205(99)00497-X","volume":"65","author":"H Kanki","year":"1999","unstructured":"Kanki, H. et al. Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin-induced diabetic mice. Life Sci. 65, 2305\u20132313 (1999).","journal-title":"Life Sci."},{"key":"BFlaban020955_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","volume":"12","author":"GH Tesch","year":"2007","unstructured":"Tesch, G.H. & Allen, T.J. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 12, 261\u2013266 (2007).","journal-title":"Nephrology (Carlton)"},{"key":"BFlaban020955_CR20","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.2741\/2400","volume":"12","author":"H Gonzalez-Navarro","year":"2007","unstructured":"Gonzalez-Navarro, H., Burks, D.J. & Andres, V. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis. Front. Biosci. 12, 4439\u20134455 (2007).","journal-title":"Front. Biosci."},{"key":"BFlaban020955_CR21","doi-asserted-by":"publisher","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","volume":"291","author":"D An","year":"2006","unstructured":"An, D. & Rodrigues, B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am. J. Physiol. Heart. Circ. Physiol. 291, H1489\u20131506 (2006).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"BFlaban020955_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/07853890701670421","volume":"40","author":"B Jafar-Mohammadi","year":"2008","unstructured":"Jafar-Mohammadi, B. & McCarthy, M.I. Genetics of type 2 diabetes mellitus and obesity\u2014a review. Ann. Med. 40, 2\u201310 (2008).","journal-title":"Ann. Med."},{"key":"BFlaban020955_CR23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2337\/diab.34.12.1288","volume":"34","author":"R Blay","year":"1985","unstructured":"Blay, R. A, Bigley, N.J. & Giron, D.J. A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyocarditis virus and a single low dose of streptozocin. Diabetes 34, 1288\u20131292 (1985).","journal-title":"Diabetes"},{"key":"BFlaban020955_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/tcm.1039","volume":"22","author":"A Fein","year":"2002","unstructured":"Fein, A. et al. Diabetes teratogenicity in mice is accompanied with distorted expression of TGF-beta2 in the uterus. Teratog. Carcinog. Mutagen. 22, 59\u201371 (2002).","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"BFlaban020955_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cellbi.2005.08.012","volume":"30","author":"K Bloch","year":"2006","unstructured":"Bloch, K. et al. Improved activity of streptozotocin-selected insulinoma cells following microencapsulation and transplantation into diabetic mice. Cell. Biol. Int. 30, 138\u2013143 (2006).","journal-title":"Cell. Biol. Int."},{"key":"BFlaban020955_CR26","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.biocel.2007.05.022","volume":"39","author":"M Wang","year":"2007","unstructured":"Wang, M. et al. Glucose regulated proteins 78 protects insulinoma cells (NIT-1) from death induced by streptozotocin, cytokines or cytotoxic T lymphocytes. Int. J. Biochem. Cell. Biol. 39, 2076\u20132082 (2007).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"BFlaban020955_CR27","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1271\/bbb.68.2421","volume":"68","author":"T Itoh","year":"2004","unstructured":"Itoh, T. et al. Suppressive effect of a hot water extract of adzuki beans (Vigna angularis) on hyperglycemia after sucrose loading in mice and diabetic rats. Biosci. Biotechnol. Biochem. 68, 2421\u20132426 (2004).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"BFlaban020955_CR28","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1248\/bpb.23.1458","volume":"23","author":"Y Kondo","year":"2000","unstructured":"Kondo, Y., Nakatani, A., Hayashi, K. & Ito, M. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biol. Pharm. Bull. 23, 1458\u20131464 (2000).","journal-title":"Biol. Pharm. Bull."},{"key":"BFlaban020955_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0940-2993(11)80119-3","volume":"46","author":"E Kume","year":"1994","unstructured":"Kume, E., Ohmachi, Y., Itagaki, S., Tamura, K. & Doi, K. Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes. Exp. Toxicol. Pathol. 46, 368\u2013374 (1994).","journal-title":"Exp. Toxicol. Pathol."},{"key":"BFlaban020955_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1078\/0940-2993-00351","volume":"55","author":"E Kume","year":"2004","unstructured":"Kume, E. et al. Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice. Exp. Toxicol. Pathol. 55, 467\u2013480 (2004).","journal-title":"Exp. Toxicol. Pathol."},{"key":"BFlaban020955_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2337\/diabetes.49.8.1341","volume":"49","author":"E Montanya","year":"2000","unstructured":"Montanya, E., Nacher, V., Biarnes, M. & Soler, J. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy. Diabetes 49, 1341\u20131346 (2000).","journal-title":"Diabetes"},{"key":"BFlaban020955_CR32","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.2337\/diabetes.54.9.2596","volume":"54","author":"WL Suarez-Pinzon","year":"2005","unstructured":"Suarez-Pinzon, W.L., Yan, Y., Power, R., Brand, S.J. & Rabinovitch, A. Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54, 2596\u20132601 (2005).","journal-title":"Diabetes"},{"key":"BFlaban020955_CR33","doi-asserted-by":"publisher","first-page":"27080","DOI":"10.1074\/jbc.M211947200","volume":"278","author":"C Dai","year":"2003","unstructured":"Dai, C., Li, Y., Yang, J. & Liu, Y. Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice. J. Biol. Chem. 278, 27080\u201327087 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFlaban020955_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2337\/diabetes.54.3.702","volume":"54","author":"JC Jimenez-Chillaron","year":"2005","unstructured":"Jimenez-Chillaron, J.C. et al. Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model. Diabetes 54, 702\u2013711 (2005).","journal-title":"Diabetes"},{"key":"BFlaban020955_CR35","first-page":"263","volume":"67","author":"D Grimaud","year":"2001","unstructured":"Grimaud, D. & Levraut, J. Acute postoperative metabolic complications of diabetes. Minerva Anestesiol. 67, 263\u2013270 (2001).","journal-title":"Minerva Anestesiol."},{"key":"BFlaban020955_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.numecd.2006.05.006","volume":"16","author":"A Ceriello","year":"2006","unstructured":"Ceriello, A. et al. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr. Metab. Cardiovasc. Dis. 16, 453\u2013456 (2006).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"BFlaban020955_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00001573-199803000-00010","volume":"13","author":"PJ Savage","year":"1998","unstructured":"Savage, P.J. Treatment of diabetes mellitus to reduce its chronic cardiovascular complications. Curr. Opin. Cardiol. 13, 131\u2013138 (1998).","journal-title":"Curr. Opin. Cardiol."},{"key":"BFlaban020955_CR38","first-page":"187","volume":"43","author":"BH Wolffenbuttel","year":"1993","unstructured":"Wolffenbuttel, B.H. Type 2 diabetes mellitus. Aspects of com-plications and treatment. Neth. J. Med. 43, 187\u2013199 (1993).","journal-title":"Neth. J. Med."},{"key":"BFlaban020955_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10047-003-0219-7","volume":"6","author":"JM Wojcicki","year":"2003","unstructured":"Wojcicki, J.M. & Ladyzynski, P. Toward the improvement of diabetes treatment: recent developments in technical support. J. Artif. Organs 6, 73\u201387 (2003).","journal-title":"J. Artif. Organs"},{"key":"BFlaban020955_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0026-0495(98)90027-0","volume":"47","author":"J Luo","year":"1998","unstructured":"Luo, J. et al. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47, 663\u2013668 (1998).","journal-title":"Metabolism"}],"container-title":["Lab Animal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/laban0209-55","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/laban0209-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/laban0209-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:17:07Z","timestamp":1738887427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/laban0209-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFlaban020955"],"URL":"https:\/\/doi.org\/10.1038\/laban0209-55","relation":{},"ISSN":["0093-7355","1548-4475"],"issn-type":[{"value":"0093-7355","type":"print"},{"value":"1548-4475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}